ASCO GI 2020: Duration to Deterioration Is Three Times Longer Than Standard of Care in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab + Bevacizumab
Quality of life is maintained longer with the combination.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.